Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 12/2016

01-12-2016 | Original Article

Preoperative High Dose of Methylprednisolone Improves Early Postoperative Pulmonary Function, in Super-Obese Patients Undergoing Open Surgery; a Prospective, Comparative Study

Authors: George Skroubis, George Theofanis, Charalampos Spyropoulos, Anastasia Zotou, Petros Constantinopoulos, Fotis Kalfarentzos, Theodore Alexandrides

Published in: Journal of Gastrointestinal Surgery | Issue 12/2016

Login to get access

Abstract

Background

Surgery stimulates an intense systemic inflammatory response which might increase postoperative morbidity. Corticosteroids may reduce this inflammatory reaction. The purpose of this study was to investigate any possible effect on postoperative morbidity and recovery after administrating methylprednisolone in super-obese patients undergoing open surgery.

Methods

Sixty super-obese patients with BMI ≥50 kg/m2 (mean 57.48 ± 7.33), mean age of 39 ± 9 years, who underwent an open bariatric procedure, were enrolled. Thirty patients (group A) were allocated to a preoperative single dose of 30 mg/kg (ideal body weight) methylprednisolone versus placebo (group B, 30 patients). Endpoints included assessment of IL-6 and CRP; evaluation of postoperative pulmonary function, pain management, nausea, and vomiting; and documentation of postoperative complications.

Results

Significant improvement in spirometry parameters and arterial blood gas analysis, in the first and third postoperative days, was observed in the methylprednisolone group. IL-6 and CRP levels were significantly lower in that group. Administration of methylprednisolone was associated with less postoperative pain, nausea, and vomiting, with no statistical difference in septic complications.

Conclusions

Preoperative administration of a single high dose of methylprednisolone in super-obese patients undergoing open surgery inhibits the inflammatory signaling cascade, lessens the systemic inflammatory response, and results in fewer pulmonary complications and better patient recovery.
Literature
1.
go back to reference Wilmore DW. Metabolic response to severe surgical illness: overview. World J Surg 2000; 24: 705–11CrossRefPubMed Wilmore DW. Metabolic response to severe surgical illness: overview. World J Surg 2000; 24: 705–11CrossRefPubMed
3.
go back to reference Gabay C, Kushner I. Acute phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448–54CrossRefPubMed Gabay C, Kushner I. Acute phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448–54CrossRefPubMed
4.
go back to reference Johnson JL, Moore EE, Tamura DY, Zallen G, Biffl WL, Silliman CC. Interleukin-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release. J Surg Res 1998; 76: 91–4CrossRefPubMed Johnson JL, Moore EE, Tamura DY, Zallen G, Biffl WL, Silliman CC. Interleukin-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release. J Surg Res 1998; 76: 91–4CrossRefPubMed
5.
go back to reference Oka Y, Murata A, Nishijima J, Yasuda T, Hiraoka N, Ohmachi Y, Kitagawa K, Yasuda T, Toda H, Tanaka N. Circulating interleukin 6 as a useful marker for predicting postoperative complications. Cytokine 1992; 4: 298 – 304CrossRefPubMed Oka Y, Murata A, Nishijima J, Yasuda T, Hiraoka N, Ohmachi Y, Kitagawa K, Yasuda T, Toda H, Tanaka N. Circulating interleukin 6 as a useful marker for predicting postoperative complications. Cytokine 1992; 4: 298 – 304CrossRefPubMed
6.
go back to reference Holte K, Kehlet H. Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications. J Am Coll Surg 2002; 195: 694–712CrossRefPubMed Holte K, Kehlet H. Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications. J Am Coll Surg 2002; 195: 694–712CrossRefPubMed
7.
go back to reference Srinivasa S, Kahokehr AA, Yu TC, Hill AG. Preoperative glucocorticoid use in major abdominal surgery: systematic review and meta-analysis of randomized trials. Ann Surg 2011; 254: 183–191CrossRefPubMed Srinivasa S, Kahokehr AA, Yu TC, Hill AG. Preoperative glucocorticoid use in major abdominal surgery: systematic review and meta-analysis of randomized trials. Ann Surg 2011; 254: 183–191CrossRefPubMed
8.
go back to reference Engelman E, Maeyens C. Effect of preoperative single-dose corticosteroid administration on postoperative morbidity following esophagectomy. J Gastrointest Surg 2010; 14: 788–804CrossRefPubMed Engelman E, Maeyens C. Effect of preoperative single-dose corticosteroid administration on postoperative morbidity following esophagectomy. J Gastrointest Surg 2010; 14: 788–804CrossRefPubMed
9.
go back to reference Barber AE, Coyle SM, Fischer E, Smith C, van der Poll T, Shires GT, Lowry SF. Influence of hypercortisolemia on soluble tumor necrosis factor receptor II and interleukin-1 receptor antagonist responses to endotoxin in human beings. Surgery 1995; 118: 406–10CrossRefPubMed Barber AE, Coyle SM, Fischer E, Smith C, van der Poll T, Shires GT, Lowry SF. Influence of hypercortisolemia on soluble tumor necrosis factor receptor II and interleukin-1 receptor antagonist responses to endotoxin in human beings. Surgery 1995; 118: 406–10CrossRefPubMed
10.
go back to reference Kehlet H, Dahl JB. Anaesthesia, surgery, and challenges in postoperative recovery. Lancet 2003; 362: 1921–8CrossRefPubMed Kehlet H, Dahl JB. Anaesthesia, surgery, and challenges in postoperative recovery. Lancet 2003; 362: 1921–8CrossRefPubMed
11.
go back to reference Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) 1998; 94: 557–72CrossRef Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) 1998; 94: 557–72CrossRef
12.
go back to reference La Vignera S, Condorelli R, Bellanca S, La Rosa B, Mousaví A, Busa B, Vicari LO, Vicari E. Obesity is associated with a higher level of pro-inflammatory cytokines in follicular fluid of women undergoing medically assisted procreation (PMA) programs. Eur Rev Med Pharmacol Sci 2011; 15: 267–73PubMed La Vignera S, Condorelli R, Bellanca S, La Rosa B, Mousaví A, Busa B, Vicari LO, Vicari E. Obesity is associated with a higher level of pro-inflammatory cytokines in follicular fluid of women undergoing medically assisted procreation (PMA) programs. Eur Rev Med Pharmacol Sci 2011; 15: 267–73PubMed
13.
go back to reference Chung MY, Hong SJ, Lee JY. The influence of obesity on postoperative inflammatory cytokine levels. J Int Med Res 2011; 39: 2370–8CrossRefPubMed Chung MY, Hong SJ, Lee JY. The influence of obesity on postoperative inflammatory cytokine levels. J Int Med Res 2011; 39: 2370–8CrossRefPubMed
14.
go back to reference Anty R, Bekri S, Luciani N, Saint-Paul MC, Dahman M, Iannelli A, Amor IB, Staccini-Myx A, Huet PM, Gugenheim J, Sadoul JL, Le Marchand-Brustel Y, Tran A, Gual P. The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH. Am J Gastroenterol 2006; 101: 1824–33CrossRefPubMed Anty R, Bekri S, Luciani N, Saint-Paul MC, Dahman M, Iannelli A, Amor IB, Staccini-Myx A, Huet PM, Gugenheim J, Sadoul JL, Le Marchand-Brustel Y, Tran A, Gual P. The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH. Am J Gastroenterol 2006; 101: 1824–33CrossRefPubMed
15.
go back to reference Aleman JO, Eusebi LH, Ricciardiello L, Patidar K, Sanyal AJ, Holt PR. Mechanism of obesity-induced gastrointestinal neoplasia. Gastroenterology 2014; 146: 357–73CrossRefPubMed Aleman JO, Eusebi LH, Ricciardiello L, Patidar K, Sanyal AJ, Holt PR. Mechanism of obesity-induced gastrointestinal neoplasia. Gastroenterology 2014; 146: 357–73CrossRefPubMed
16.
go back to reference Kalfarentzos F, Skroubis G, Karamanakos S, Argentou M, Mead N, Kehagias I, Alexandrides TK. Biliopancreatic diversion with Roux-en-Y gastric bypass and long limbs: advances in surgical treatment for super-obesity. Obes Surg 2011; 21: 1849–58CrossRefPubMed Kalfarentzos F, Skroubis G, Karamanakos S, Argentou M, Mead N, Kehagias I, Alexandrides TK. Biliopancreatic diversion with Roux-en-Y gastric bypass and long limbs: advances in surgical treatment for super-obesity. Obes Surg 2011; 21: 1849–58CrossRefPubMed
17.
go back to reference Bloomston M, Zervos EE, Camps MA, Goode SE, Rosemurgy AS. Outcome following bariatric surgery in super versus morbidly obese patients: does weight matter? Obes Surg 1997; 7: 414–9CrossRefPubMed Bloomston M, Zervos EE, Camps MA, Goode SE, Rosemurgy AS. Outcome following bariatric surgery in super versus morbidly obese patients: does weight matter? Obes Surg 1997; 7: 414–9CrossRefPubMed
18.
go back to reference DeMaria EJ, Portenier D, Wolfe L. Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass. Surg Obes Relat Dis 2007; 3: 134–140CrossRefPubMed DeMaria EJ, Portenier D, Wolfe L. Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass. Surg Obes Relat Dis 2007; 3: 134–140CrossRefPubMed
19.
go back to reference Demaria EJ, Murr M, Byrne TK, Blackstone R, Grant JP, Budak A, Wolfe L. Validation of the obesity surgery mortality risk score in a Multicenter Study Proves it Stratifies Gastric Bypass for Morbid Obesity. Ann Surg 2007; 246: 578–584CrossRefPubMed Demaria EJ, Murr M, Byrne TK, Blackstone R, Grant JP, Budak A, Wolfe L. Validation of the obesity surgery mortality risk score in a Multicenter Study Proves it Stratifies Gastric Bypass for Morbid Obesity. Ann Surg 2007; 246: 578–584CrossRefPubMed
20.
go back to reference Balistreri CR, Caruso C, Candore G. The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediators Inflamm 2010; 2010: 802078CrossRefPubMedPubMedCentral Balistreri CR, Caruso C, Candore G. The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediators Inflamm 2010; 2010: 802078CrossRefPubMedPubMedCentral
21.
go back to reference Zotti GC, Salzano de Luna F, Caiazza A, Santaniello W, Micheletti G, Bruno A, Casadei CL. Prevention of pulmonary complications by 6-methylprednizolone in major abdominal surgery. Ital J Surg Sci 1988; 18: 369–375PubMed Zotti GC, Salzano de Luna F, Caiazza A, Santaniello W, Micheletti G, Bruno A, Casadei CL. Prevention of pulmonary complications by 6-methylprednizolone in major abdominal surgery. Ital J Surg Sci 1988; 18: 369–375PubMed
22.
go back to reference Fecht DC, Magovern GJ, Park SB, Merkow LP, Dixon CM, Dosios T, Pardo M. Beneficial effects of methylprednisolone in patients on cardiopulmonary bypass. Circ Shock 1978; 5: 415–422PubMed Fecht DC, Magovern GJ, Park SB, Merkow LP, Dixon CM, Dosios T, Pardo M. Beneficial effects of methylprednisolone in patients on cardiopulmonary bypass. Circ Shock 1978; 5: 415–422PubMed
23.
go back to reference Pelosi P, Gregoretti C. Perioperative management of obese patients. Best Prac Res Clin Anaesth 2010; 24: 211–25CrossRef Pelosi P, Gregoretti C. Perioperative management of obese patients. Best Prac Res Clin Anaesth 2010; 24: 211–25CrossRef
24.
go back to reference Hennein HA, Ebba H, Rodriguez JL, Merrick SH, Keith FM, Bronstein MH, Leung JM, Mangano DT, Greenfield LJ, Rankin JS. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 1994; 108: 626–35PubMed Hennein HA, Ebba H, Rodriguez JL, Merrick SH, Keith FM, Bronstein MH, Leung JM, Mangano DT, Greenfield LJ, Rankin JS. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 1994; 108: 626–35PubMed
25.
go back to reference Deng MC, Dash B, Erren M, Mollhoff T, Scheld HH. Impact of left ventricular dysfunction on cytokines, hemodynamics and outcome in by-pass grafting. Ann Thorac Surg 1996; 62: 184–190CrossRefPubMed Deng MC, Dash B, Erren M, Mollhoff T, Scheld HH. Impact of left ventricular dysfunction on cytokines, hemodynamics and outcome in by-pass grafting. Ann Thorac Surg 1996; 62: 184–190CrossRefPubMed
26.
go back to reference Moussa AA, Oregan PJ. Prevention of postoperative nausea and vomiting in patient undergoing laparoscopic bariatric surgery - granisetron alone vs granisetron combined with dexamethasone/droperidol. Middle East J Anaesthesiol 2007; 19: 357 – 367PubMed Moussa AA, Oregan PJ. Prevention of postoperative nausea and vomiting in patient undergoing laparoscopic bariatric surgery - granisetron alone vs granisetron combined with dexamethasone/droperidol. Middle East J Anaesthesiol 2007; 19: 357 – 367PubMed
27.
go back to reference Mendes MN, Monteiro Rde S, Martins FA. Prophylaxis of postoperative nausea and vomiting in morbidly obese patients undergoing laparoscopic gastroplasties: a comparative study among three methods. Rev Bras Anestesiol 2009; 59: 570–6PubMed Mendes MN, Monteiro Rde S, Martins FA. Prophylaxis of postoperative nausea and vomiting in morbidly obese patients undergoing laparoscopic gastroplasties: a comparative study among three methods. Rev Bras Anestesiol 2009; 59: 570–6PubMed
28.
go back to reference Karanicolas PJ, Smith SE, Kanbur B, Davies E, Guyatt GH. The impact of prophylactic dexamethasone on nausea and vomiting after laparoscopic cholecystectomy: a systematic review and meta-analysis. Ann Surg 2008; 248: 751–62CrossRefPubMed Karanicolas PJ, Smith SE, Kanbur B, Davies E, Guyatt GH. The impact of prophylactic dexamethasone on nausea and vomiting after laparoscopic cholecystectomy: a systematic review and meta-analysis. Ann Surg 2008; 248: 751–62CrossRefPubMed
29.
go back to reference Henzi I, Walder B, Tramer MR. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systemic review. Anesth Analg 2000; 90: 186–194CrossRefPubMed Henzi I, Walder B, Tramer MR. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systemic review. Anesth Analg 2000; 90: 186–194CrossRefPubMed
30.
go back to reference Hargreaves KM, Costello A. Glucocorticoids levels of immunoreactive bradykinin in inflamed tissue as evaluated by microdialysis probes. Clin Pharmacol Ther 1990; 48: 168–178CrossRefPubMed Hargreaves KM, Costello A. Glucocorticoids levels of immunoreactive bradykinin in inflamed tissue as evaluated by microdialysis probes. Clin Pharmacol Ther 1990; 48: 168–178CrossRefPubMed
31.
go back to reference Feld JM, Hoffman WE, Stechert MM, Hoffman IW, Ananda RC. Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. J Clin Anest 2006; 18: 24–8CrossRef Feld JM, Hoffman WE, Stechert MM, Hoffman IW, Ananda RC. Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. J Clin Anest 2006; 18: 24–8CrossRef
32.
go back to reference Yared JP, Starr NJ, Torres FK, Bashour CA, Bourdakos G, Piedmonte M, Michener JA, Davis JA, Rosenberger TE. Effects of single dose, postinduction dexametathasone on recovery after cardiac surgery. Ann Thorac Surg 2000; 69: 1420–73CrossRefPubMed Yared JP, Starr NJ, Torres FK, Bashour CA, Bourdakos G, Piedmonte M, Michener JA, Davis JA, Rosenberger TE. Effects of single dose, postinduction dexametathasone on recovery after cardiac surgery. Ann Thorac Surg 2000; 69: 1420–73CrossRefPubMed
Metadata
Title
Preoperative High Dose of Methylprednisolone Improves Early Postoperative Pulmonary Function, in Super-Obese Patients Undergoing Open Surgery; a Prospective, Comparative Study
Authors
George Skroubis
George Theofanis
Charalampos Spyropoulos
Anastasia Zotou
Petros Constantinopoulos
Fotis Kalfarentzos
Theodore Alexandrides
Publication date
01-12-2016
Publisher
Springer US
Published in
Journal of Gastrointestinal Surgery / Issue 12/2016
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-016-3281-1

Other articles of this Issue 12/2016

Journal of Gastrointestinal Surgery 12/2016 Go to the issue